Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

New treatments for hair loss are being developed using molecular biology.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Adipose tissue shows promise for hair regrowth, but more research is needed to confirm best practices and effectiveness.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

LLLT is a safe, promising hair loss treatment, but more research needed.

Finasteride affects offspring's antioxidant enzymes in epididymis, possibly disrupting sperm maturation.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Spironolactone most effective for hirsutism, but has side effects.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Certain drugs that block specific enzymes can help treat prostate diseases.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.